Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Geert Vanden Bossche

Geert Vanden Bossche

VaReCo, Belgium Belgium

Melody Janssen

Melody Janssen

N4 Pharma Plc., UK UK

Pierre A MORGON

Pierre A MORGON

MRGN Advisors, Switzerland Switzerland

Gerald C. Hsu

Gerald C. Hsu

Eclaire MD Foundation, USA USA

Clyde A Smith

Clyde A Smith

Stanford University, USA USA

A. C. Matin

A. C. Matin

Stanford University School of Medicine, USA USA

Andrea Fritzer

Andrea Fritzer

Valneva Austria GmbH, Austria Austria

Anthony Gilbert

Anthony Gilbert

hVIVO, UK UK

Euro Vaccines 2020

ABOUT CONFERENCE

On behalf of the Vaccines Advisory Committee we take great pleasure in welcoming academic scientists, researchers, research scholars, students and experts of application fields to Frankfurt, Germany for the 38th Euro Global Summit and Expo on Vaccines & Vaccination to foster the advancement in the field by contributing with your expertise to what promises to be a very comprehensive and exciting meeting in the fascinating location of Frankfurt.

38th Euro Global Summit and Expo on Vaccines & Vaccination (Euro Vaccines 2020), is going to be held during June 08-09, 2020 in Frankfurt, Germany. The vaccines conference is attracting global participant’s intent on sharing, exchanging and exploring new avenues of Vaccines and Immunology Research & Development. The event will have Plenary speakers, established Keynote speakers, young researchers presentations and poster presentations. In addition, there will be poster presentations along with workshops and special sessions would be interested in audience.

The aim of the Vaccines Conferences is to promote quality research and real-world impact in an atmosphere of true international cooperation between scientists by bringing together the world class researchers, International Communities and Industrial heads to discuss the latest developments and innovations in the fields of Vaccines and Immunology.

We sincerely hope that Euro Vaccines 2020 serves as an international platform for meeting researchers from around the world, widen professional contact and create new opportunities, including establishing new collaborations.

We are looking forward to seeing you at Euro Vaccines 2020 in Frankfurt, Germany.

SESSION/TRACKS

Track 1: Human Vaccines - Infectious & Non Infectious Diseases

vaccine is an inactivated form of bacteria or virus that is injected into the body to simulate an actual infection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate an immune response by the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate the immune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

European Society for Paediatric Infectious DiseasesEuropean Union Geriatric Medicine SocietyEuropean Federation of Immunological SocietiesEuropean Academy of Allergy and Clinical ImmunologyRoyal Society of LondonEpidemiological Society of LondonEdward Jenner Society

USA:

The Anti-Vaccination Society of AmericaInfectious Diseases Society of AmericaAssociation of Immunization ManagersClinical Immunology Society

Asia and Middle-East:

Japanese Society for ImmunologySingaporean Society for ImmunologyAustralasian Society of Clinical Immunology and Allergy

Track 2: Vaccine Research & Development

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

European Academy of PaediatricsEuropean Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine SocietyGlobal Polio Eradication Initiative   

Asia and Middle-East:

Lebanese Society of Allergy and ImmunologyMoldavian Society of Allergology & ImmunologyMoroccan Society of Allergology and Clinical Immunology

Track 3: Next-Generation Vaccine Delivery Technologies

Drug delivery systems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug delivery—such as transport in the circulatory system and drug movement through cells and tissues—they have contributed to the development of a number of new modes of drug delivery that have entered clinical practice.  Role of vaccine delivery technologies includes rational development of vaccines, achieving immunization goals, supporting best clinical practice.

Vaccines continue to revolutionize our ability to prevent disease and improve health. With every technological advance, we are able to extend the benefits of vaccines to more people and provide better protection from life-threatening infectious diseases.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

European Society for ImmunodeficiencyFrench Society of ImmunologyImmunology of Diabetes SocietyDeutsche Gesellschaft für Immunologie

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAPARI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 4: Vaccines Safety & Efficacy

Vaccines are the best defense we have against serious, preventable, and sometimes deadly contagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

Croatian Society of Allergology and Clinical ImmunologyCzech Society of Allergology and Clinical ImmunologyFinnish Society of Allergology and Clinical ImmunologyFrench Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical ImmunologyParaguayan Society of Allergy, Asthma, and ImmunologyPeruvian Society of Allergy and ImmunologyVenezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and ImmunologyTaiwan Academy of Pediatric Allergy Asthma ImmunologyVietnam Association of Allergy, Asthma and Clinical Immunology

Track 5: Vaccines Business Development

Collaboration plays a major part in the success of Vaccines Business. This is exemplified in the relationships built, products launched and lives improved.

Vaccines Business development: comprise a number of tasks and processes generally aiming at developing and implementing growth opportunities within and between organizations. It is a subset of the fields of business, commerce and organizational theory. Vaccine development programs face several challenges that set them apart from other types of healthcare product development programs.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

Croatian Society of Allergology and Clinical ImmunologyCzech Society of Allergology and Clinical ImmunologyFinnish Society of Allergology and Clinical ImmunologyFrench Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical ImmunologyParaguayan Society of Allergy, Asthma, and ImmunologyPeruvian Society of Allergy and ImmunologyVenezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and ImmunologyTaiwan Academy of Pediatric Allergy Asthma ImmunologyVietnam Association of Allergy, Asthma and Clinical Immunology

Track 6: Vaccine Adjuvants

Vaccine adjuvants – is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s.  Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

European Society for ImmunodeficiencyFrench Society of ImmunologyImmunology of Diabetes Society; Deutsche Gesellschaft für ImmunologieRoyal Society of LondonEpidemiological Society of London; Edward Jenner Society

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAPARI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 7: HIV/AIDS Vaccines

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A “preventive” vaccine would stop HIV infection occurring altogether, whereas a “therapeutic” vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV. 

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

European Society for ImmunodeficiencyFrench Society of ImmunologyImmunology of Diabetes SocietyDeutsche Gesellschaft für Immunologie

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAPARI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 8: Immunology/Animal Models

Observations in animal models have substantially advanced our knowledge of immune system adaptation, changes during the aging process, and age-associated degenerative diseases with autoimmune characteristics.

Animal models provided early proof that discrimination of self (that which the immune system identifies as belonging to the body) and non-self (that which the immune system identifies as foreign to the body) is determined not entirely at conception, but, to a large extent, during early fetal development by a process called immune adaptation. The animal experiments confirmed the premise that immune adaptation is determined by the fetal or neonatal environment, rather than inherited. Animal models have substantially enhanced our understanding of the role of the immune system in tissue physiology and pathology. The knowledge gained from animal models offers hope for future modification of the human immune system to combat a number of disease processes.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

British Society for ImmunologyMicrobiology Society, London; Royal Society of LondonEpidemiological Society of LondonEdward Jenner SocietySociety for Applied MicrobiologyEuropean Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology SocietiesThe American Association of ImmunologistsAmerican Society for MicrobiologyColombian Allergy, Asthma and Immunology AssociationCanadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical ImmunologyAustralasian Society of Clinical Immunology and AllergyBangladesh Society of Allergy and Immunology

Track 9: Childhood Vaccines and Maternal Vaccines

Vaccination given to children is called children Immunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system or neurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.

We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. That’s why it’s important that children, especially infants and young children receive recommended immunizations on time.

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning a pregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you. Tetanus/Diphtheria/Pertussis (Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.

Related Vaccines Conferences | Immunology Conferences World Vaccine Congress

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine SocietyGlobal Polio Eradication Initiative   

Asia and Middle-East:

Lebanese Society of Allergy and ImmunologyMoldavian Society of Allergology & ImmunologyMoroccan Society of Allergology and Clinical Immunology

Track 10: Human Preventive & Therapeutic Vaccines

preventative vaccine is administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases like poliochicken poxmeasles, mumps, rubella, influenza (flu), and hepatitis A and B.

In addition to preventive vaccines, there are also “therapeutic vaccines”. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as “therapeutic immunogens.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

Swiss Society for MicrobiologyFederation of European Microbiological SocietiesInternational Society of VaccinesInternational Union of Immunological SocietyRoyal Society of LondonEpidemiological Society of LondonEdward Jenner Society

USA:

Ecuadorian Society of Allergy, Asthma, and ImmunologyGuatemalan Allergy, Asthma and Clinical Immunology AssociationHonduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and ImmunologyKorean Academy of Asthma, Allergy and Clinical ImmunologyMalaysian Society of Allergy and Immunology

Track 11: Cancer Vaccines and Immunotherapy

Immunotherapeutics is treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:

  1. Cancer vaccines
  2. Monoclonal antibodies
  3. Immune checkpoint inhibitors
  4. Other, non-specific immunotherapies

Some types of immunotherapy are also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and they’ll impact how we treat cancer in the future.

Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine SocietyGlobal Polio Eradication Initiative   

Asia and Middle-East:

Lebanese Society of Allergy and ImmunologyMoldavian Society of Allergology & ImmunologyMoroccan Society of Allergology and Clinical Immunology

Track 12: Vaccines for Vector-borne Diseases

Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. Vector-borne diseases are among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.

Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.  Malaria was driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.

In contrast to expenditure and effort on medicine, diagnostic and vaccine development, relatively little attention was given to vector control in the past.  The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.

Related Vaccines Conferences | Immunology Conferences World Vaccine Congress

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL); Medical Research Council (MRC); Royal Society of LondonEpidemiological Society of LondonEdward Jenner Society

USA:

Hepatitis B Foundation (HBF); Infectious Diseases Society of America (IDSA); National Adult and Influenza Immunization Summit (NAIIS); National Foundation for Infectious Diseases (NFID); Paediatrics Infectious Diseases Society (PIDS)

Asia and Middle-East:

Russian Association of Allergology and Clinical ImmunologyTurkish National Society of Allergy and Clinical ImmunologyUkrainian Association of Allergologists and Clinical Immunologists

Track 13:  Vaccines for Older Adults

Vaccines are an important part of routine preventive care for older adults, but most adults don’t get their vaccines as recommended. Omitting vaccination leaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death from infectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

British Society for Allergy and Clinical ImmunologyBritish Society for Histocompatibility and ImmunogeneticsEuropean Federation of Immunological SocietiesEuropean Academy of Allergology and Clinical Immunology

USA:

Voices for Vaccines (VFV); National Institute of Allergy and Infectious Disease (NIAID); American Public Health Association (APHA); American Association for the Advancement of Science (AAAS); American Society for Microbiology (ASM)

Asia and Middle-East:

Australasian Society for ImmunologyAustralasian Society of Clinical Immunology and AllergyIsrael Association of Allergy and Clinical ImmunologyJordanian Society for Allergy and Clinical ImmunologyJapanese Society for Immunology

Track 14: Veterinary Vaccines

Veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL); Medical Research Council (MRC)

USA:

Hepatitis B Foundation (HBF); Infectious Diseases Society of America (IDSA); National Adult and Influenza Immunization Summit (NAIIS); National Foundation for Infectious Diseases (NFID); Paediatrics Infectious Diseases Society (PIDS)

Asia and Middle-East:

Russian Association of Allergology and Clinical ImmunologyTurkish National Society of Allergy and Clinical ImmunologyUkrainian Association of Allergologists and Clinical Immunologists

Track 15: Vaccines against Viral and Bacterial Diseases

Most vaccines against viral infection are effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.

It is difficult for many of us today to appreciate the dangers of childhood viral infections.

Most of the vaccines in use against viruses are very effective at preventing disease. However, for a variety of reasons, they can fail:

  • The vaccine becomes inactive due to incorrect storage, if used past its expiry date, or if incorrectly administered.
  • Individuals unpredictably fail to produce an adequate immune response to the vaccine.
  • Vaccine immunity “fades” over time.

 The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.

Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.

Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available against tuberculosisdiphtheriatetanuspertussis, Haemophilus influenzae type B, cholera, typhoid, and Streptococcus pneumoniae.

Related Vaccines Conferences | Immunology Conferences World Vaccine Congress

Related Societies:

Europe:

European Society for Paediatric Infectious DiseasesEuropean Union Geriatric Medicine SocietyEuropean Federation of Immunological SocietiesEuropean Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of AmericaRoyal Society of LondonEpidemiological Society of LondonEdward Jenner SocietyInfectious Diseases Society of AmericaAssociation of Immunization ManagersClinical Immunology Society

Asia and Middle-East:

Japanese Society for ImmunologySingaporean Society for ImmunologyAustralasian Society of Clinical Immunology and Allergy

Track 16: Vaccines for Respiratory Diseases

Population protection by vaccination against infections has been one of the major achievements of public health and is of considerable importance in controlling respiratory diseases.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

British Society for Allergy and Clinical ImmunologyBritish Society for Histocompatibility and ImmunogeneticsEuropean Federation of Immunological SocietiesEuropean Academy of Allergology and Clinical Immunology

USA:

Voices for Vaccines (VFV); National Institute of Allergy and Infectious Disease (NIAID); American Public Health Association (APHA); American Association for the Advancement of Science (AAAS); American Society for Microbiology (ASM)

Asia and Middle-East:

Australasian Society for ImmunologyAustralasian Society of Clinical Immunology and AllergyIsrael Association of Allergy and Clinical ImmunologyJordanian Society for Allergy and Clinical ImmunologyJapanese Society for Immunology

Track 17: DNA Vaccines

DNA vaccination is a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

Vaccination consists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime the immune system.

The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing the immune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

Albanian Society of Allergology and Clinical ImmunologyAustrian Society of Allergology and Immunology; Belgian Society of Allergy and Clinical ImmunologyBritish Society of Allergy and Clinical Immunology; Royal Society of LondonEpidemiological Society of LondonEdward Jenner Society

USA:

Argentine Association of Allergy and ImmunologyArgentine Society of Allergy and ImmunologyBrazilian Society of Allergy and ImmunologyChilean Society of Allergy and Immunology

 Asia and Middle-East:

Allergy & Immunology Society of Sri LankaAllergy and Clinical Immunology Society of SingaporeAllergy and Immunology Society of Thailand

Track 18: Hepatitis Vaccines

Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis.

There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.

Hepatitis A and E are typically caused by ingestion of contaminated food or water. Hepatitis B, C and D usually occur as a result of parenteral contact with infected body fluids. Common modes of transmission for these viruses include receipt of contaminated blood or blood products, invasive medical procedures using contaminated equipment and for hepatitis B transmission from mother to baby at birth, from family member to child, and also by sexual contact.

Acute infection may occur with limited or no symptoms, or may include symptoms such as jaundice (yellowing of the skin and eyes), dark urine, extreme fatigue, nausea, vomiting and abdominal pain.

Related Vaccines Conferences Immunology Conferences | World Vaccine Congress

Related Societies:

Europe:

British Society for ImmunologyMicrobiology Society, London; Society for Applied MicrobiologyEuropean Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology SocietiesThe American Association of ImmunologistsAmerican Society for MicrobiologyColombian Allergy, Asthma and Immunology AssociationCanadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical ImmunologyAustralasian Society of Clinical Immunology and AllergyBangladesh Society of Allergy and Immunology

Track 19: Mucosal Vaccines

Most infectious agents enter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosal immune system (dispersed or organised into units such as Peyer’s patches in the intestine or the nasal-associated lymphoid tissue in the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

Related Vaccines Conferences | Immunology Conferences World Vaccine Congress

Related Societies:

Europe:

Swiss Society for MicrobiologyFederation of European Microbiological SocietiesInternational Society of VaccinesRoyal Society of LondonEpidemiological Society of LondonEdward Jenner SocietyInternational Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and ImmunologyGuatemalan Allergy, Asthma and Clinical Immunology AssociationHonduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and ImmunologyKorean Academy of Asthma, Allergy and Clinical ImmunologyMalaysian Society of Allergy and Immunology

MARKET ANALYSIS

Vaccines Conferences advisory board invites all the participants across the world to attend “38th Euro Global Summit and Expo on Vaccines & Vaccination” going to be held during June 08-09, 2020 in Frankfurt, Germany. The Theme of the conference is "Focusing on novel strategies in Vaccines and Immunology Research" will explore the advances in Vaccines and Vaccination.

Importance & Scope:

This conference could be an exceptional event that brings along a novel and International mixture of huge and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization. Euro Vaccines 2020 amasses all the extroverts under one roof of current advances.

Market Growth of Vaccine Research in the last and upcoming ten years

The global vaccines market is one of the fastest growing segments and new predictions estimate the value of the market to reach between $48 billion and more than $70 billion over the next five to eight years.

According to a new report released by Transparency Market Research, the value of the global human vaccines market is expected to grow from a $28.3 billion in 2015 to $72.5 billion in 2024. The projection would represent a compound annual growth rate (CAGR) of 11.2% from 2016 to 2024. Even though the dollar figure is large and growing, vaccines still only account 3% of the market share within the global pharmaceutical industry. The report broke down expectations by segments. By age group, paediatric vaccines accounted for 57.5% of the share in 2015, but adult vaccines are expected to grow at a 13.2% CAGR during the forecast period. When the research group analysed the market by product, they found the pneumococcal segment to have the majority share in 2015, but expect hepatitis products to demonstrate strong growth through 2024. By vaccine type, the conjugate vaccines held the majority share in 2015, but the combination vaccines were expected to have the largest CAGR.

LEARN MORE

Latest Scope, Research and Innovation in Vaccines

Vaccines Companies

Vaccines Companies in Europe: Hookipa Biotech | s-TARget Therapeutics | Valneva | GlaxoSmithKline | AXON Neuroscience | Bavarian Nordic | Onxeo | Vibalogics | BioNTech | Immatics Biotechnologies | MSD (Merck) | Okairos | Bilthoven Biologicals | ISA Pharmaceuticals | Ferrer | 2A Pharma | Anergis | Amal Therapeutics | AFFiRiS | Themis Bioscience | DanDrit Biotechnology | Abivax | InnaVirVax | APCure | Imaxio | Vaxon Biotech | VitamFero | Theravectys | Bial | Aelix Therapeutics | Mymetics | Treos Bio | Prokarium | Glide Technologies | Midatech | PsiOxus Therapeutics | ImmunoBiology (ImmBio) | Seqirus (CSL) | Scancell | Allergy Therapeutics | Oryx Translational Medicine | Provecs Medical | Vicinivax | DCPrime | ImmuneTune | Immunovo | Absynth Biologics | Oxford Vacmedix | Vaccitech

Vaccines Companies in USA:  IGNITE Immunotherapy | Dynavax Technologies | Novartis Diagnostics | Entest Biomedical | ImmunoScience | Inovio Pharmaceuticals | MediGene | Novartis | Pfene | Vical | Pfizer | Celldex Therapeutics | Protein Sciences | Opko Health | GeneCure Biotechnologies | CSL Behring | Akorn | Antera Therapeutics | Matrivax Research & Development | Merck | Affinivax | Genocea Bioscience | Sanofi Pasteur | VBI Vaccines | Berg | Agenus | Xenetic Biosciences | Selecta Biosciences | PharmAthene | Medigen | MedImmune (AstraZeneca) | Altimmune | Emergent Biosolutions | Biologics Resources | Integrated BioTherapeutics | Sanaria | Wellstat Group | NanoBio | Takeda Vaccines | Liquidia Technologies | NovaDigm Therapeutics | Immunotope | Immunovaccine | Bellicum Pharmaceuticals | Cascadian Therapeutics | EpiThany | Etubics | Immune Design | Akshaya BIO | InterveXion Therapeutics | Cascadian Therapeutics | Gritstone Oncology | SutroVax  | CardioVax | Tolerion | PaxVax | Adamis Pharmaceuticals | BioMedicure | MabVax Therapeutics | Polynoma | Galena Biopharma | Meissa Vaccines | Vaxart | Altravax | ImmunoCellular Therapeutics | Sinovac Biotech | Vivaldi Biosciences | EpitoGenesis | Nanotherapeutics | TapImmune | Aurora Biopharma | GeoVax | Inhibikase Therapeutics | TremRx | Immudicon | ImmusanT | Neon Therapeutics | Alopexx Vaccine (Alopexx) | OncoPep | Antigen Express (Generex Biotechnology) | PathoVax | Biofactura | Biological Mimetics | Neuralstem | Immunomic Therapeutics | SynAm Vaccine | Immunophotonics  | Sequoia Sciences | Heat Biologics | Annias Immunotherapeutics | Advaxis | Agilvax | Codagenix | United Biomedical | Intellect Neurosciences | Alpha-1 Biologics | TechnoVax | PnuVax | IgY Immune Technologies & Life Sciences | Najit Technologies | UbiVac | Avax Technologies | Molecular Targeting Technologies (MTTI) | Vitruvian Biomedical | TRIA Biosciences | FluGen | Madison Vaccines

Vaccines Companies in Asia & Vaccines Companies in Middle-East: Bharat Biotech | Indian Immunologicals | Shantha (Sanofi) | Panacea Biotec | Adimmune (Taichung) | Medigen Vaccine Biologics | Lipotek | Admedus | Gamma Vaccines | Sementis | BioDiem | Vaxxas Nanopatch | Sinovac Biotech | Haffkine Biopharmaceuticals | Sentinext Therapeutics | Rhapsody Biologics

List of Vaccines

Adenovirus vaccines | Alzheimer's disease amyloid protein vaccines | Bacterial diseases Vaccines  | BCG vaccine | Breast cancer vaccine | Cancer Vaccine | Caries vaccine | Chagas disease vaccine | Cholera vaccine | Coxsackie B virus vaccine | Cytomegalovirus vaccine | Dengue vaccine | Diphtheria-Tetanus toxoids (DT-dT) | Diphtheria-Tetanus-wPertussis vaccine (DTwP)  | DPT vaccine | DTaP vaccine | DTwP-Hep B vaccine | DTwP-HepB-Hib vaccine | DTwP-Hib vaccine | DTwP-IPV | DTwP-IPV-Hep B vaccine | DTwP-IPV-Hep B-Hib vaccine | Eastern Equine encephalitis virus vaccine | Ebola vaccine | Ehrlichiosis vaccine | Enterovirus 71 vaccine | Epstein–Barr vaccine | Haemophilus influenzae type b vaccine | Hepatitis A vaccine | Hepatitis B vaccine | Hepatitis C vaccine | Hepatitis E vaccine | Hib vaccine | HIV vaccine | Hookworm vaccine | HPV vaccine | HTLV-1 T-lymphotropic leukemia vaccine | Influenza vaccine | IPV | Japanese encephalitis vaccine | Leprosy vaccine | Lyme disease vaccine | Malaria vaccine | Marburg virus disease vaccine | Measles vaccine |  Measles-Mumps-Rubella vaccine (MMR) | Measles-Rubella vaccine (MR) | Meningococcal A+C +W polysaccharide vaccine | Meningococcal A+C polysaccharide vaccine | Meningococcal conjugate vaccine | Meningococcal vaccine | MMR vaccine | MMRV vaccine | Mumps vaccine | Norovirus vaccine | Onchocerciasis river blindness vaccine | OPV | Oral Cholera vaccine | Ovarian cancer vaccine | Pertussis vaccine | Pneumococcal conjugate vaccine | Pneumococcal polysaccharide vaccine | Polio vaccine | Prostate cancer vaccine | Q fever vaccine | Rabies vaccine | Respiratory syncytial virus vaccine | Rotavirus vaccine | Rubella vaccine | Schistosomiasis vaccine | Severe acute respiratory syndrome Vaccine (SARS) | Shingles Vaccine | Smallpox vaccine | Staphylococcus aureus vaccine | Streptococcus pyogenes vaccine | Syphilis vaccine | Tetanus Toxoid vaccine (TT) | Trypanosomiasis vaccine | Tuberculosis Vaccine (BCG) | Tularemia vaccine | Typhoid vaccine | Varicella vaccine | Shingles vaccine | MMRV vaccine | Visceral leishmaniasis vaccine | West Nile virus vaccine for humans | Yellow fever vaccine | Yersinia pestis vaccine | Zika fever Vaccine

Vaccines Journals

Asian Journal of Infectious Diseases | Biotechnology Advances | Cellular Immunology | Clinical and Experimental Vaccine Research | Clinical and Vaccine Immunology | Clinical Infectious Diseases | Expert Review of Vaccines | Human Vaccines and Immunotherapeutics | Immunology Letters | International Journal of Collaborative Research on Internal Medicine & Public Health | International Journal of Vaccines and Immunization | International Journal of Vaccines and Research | Journal of Allergy and Clinical Immunology | Journal of Immunological Techniques in Infectious Diseases | Journal of Vaccines & Clinical Trials | Journal of Vaccines & Vaccination | Journal of Veterinary Medical Education | Journal of Veterinary Medical Science | Journal of Veterinary Pharmacology and Therapeutics | Journal of Virological Methods | Molecular Immunology | npj Vaccines | Open Vaccine Journal | Pediatric Infection and Vaccine | Public Health | The Journal of Pediatrics | The Journal of Pediatrics | The Lancet | The Pediatric Infectious Diseases | Therapeutic Advances in Vaccines | Trials in Vaccinology | Vaccimonitor | Vaccines |  Veterinary Clinical Pathology | Veterinary Immunology and Immunopathology | Veterinary Microbiology | Virology | World Journal of Vaccines | African Journal of AIDS Research | Annual Review of Immunology | Archives of Pediatric Infectious Diseases | Cancer Immunology, Immunotherapy | Current HIV Research | European Journal of Immunology |  Immunological Reviews | International Immunology | Iranian Journal of Immunology | Journal of AIDS and Clinical Research | Journal of Clinical Immunology | Journal of Immunology | Journal of Infectious Diseases | Journal of Travel Medicine | Journal of Virology | Microbiology and Immunology | OncoImmunology | Open Immunology Journal | Open Infectious Diseases Journal | The Lancet Infectious Diseases | The Lancet HIV | Therapeutic Advances in Infectious Disease | Ticks and Tick-borne Diseases | Tropical Medicine and Health | Viral Immunology

Past Conference Report

Euro Vaccines 2019

The 36th Euro Global Summit and Expo on Vaccines & Vaccination hosted by Conferenceseries llc Ltd during June 03-04, 2019 at Park Inn by Radisson Hotel & Conference Centre London Heathrow, London, UK with a theme “Focusing on novel strategies in Vaccines research and Development” and was a great success where eminent keynote speakers, Speakers, Delegates and Poster Presenters from various reputed companies and Universities made their resplendent presence and addressed the gathering.   

Euro Vaccines 2019 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Vaccines and Therapeutics.

We would like to convey a great appreciation to following eminent people, honourable guests and Keynote speakers.

Geert Vanden Bossche, VaReCo, Belgium

Melody Janssen, N4 Pharma Plc., UK

Pierre A Morgon, MRGN Advisors, Switzerland

Special thanks to our Honorable Moderator, Dr. Anthony Gilbert, hVIVO, UK for his remarkable contribution towards smooth functioning at Euro Vaccines 2019 Conference.

Conferenceseries llc Ltd on behalf of the conference congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in presentations and sincerely wishes them success in future endeavours.

Conferenceseries llc Ltd would like to convey a warm gratitude to Chairs who contributed effervescently for the smooth functioning of the event, Melody Janssen, N4 Pharma Plc., UK.
 
Euro Vaccines 2019 conference was a great success with the support of International multi professional steering committee and coordinated by Journal of Clinical & Cellular Immunology

Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards Euro Vaccines 2019 conference, and with the enormous feedback from the participants and supporters of Euro Vaccines 2019, Conferenceseries llc Ltd is glad to announce 38th Euro Global Summit and Expo on Vaccines & Vaccination June 08-09, 2020 in Frankfurt, Germany.

Let us meet again @ Euro Vaccines 2020

 

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date June 08-09, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Cellular Immunology Journal of Immunological Techniques & Infectious Diseases Journal of Infectious Diseases & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Acquired Immune Deficiency Syndrome (AIDS)
  • Active Immunity
  • Adjuvant
  • Adverse Events
  • Allergy
  • Anaphylaxis
  • Anthrax Vaccine Adsorbed
  • Antibiotics
  • Antigenic Cartography
  • Antitoxin
  • Antiviral
  • Attenuated Vaccine
  • Autism
  • Bivalent HPV Vaccine
  • Booster Shots
  • Cell-Culture Inactivated Influenza Vaccine, Trivalent
  • Combination Vaccine
  • Community Immunity
  • Conjugate Vaccine
  • Contraindication
  • Cytomegalovirus
  • Diabetes
  • Diphtheria
  • Disease
  • Efficacy Rate
  • Encephalopathy
  • Enhanced Inactivated Polio Vaccine
  • Epidemiology
  • Gene Expression
  • Guillain-Barre Syndrome (GBS)
  • Haemophilus Influenzae Type B (Hib)
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Hepatitis D
  • Hepatitis E
  • Herd Immunity
  • Herpes Zoster
  • Hib-Meningococcal (Bivalent) Conjugate Vaccine
  • HIV-1 Vaccine
  • Host-pathogen Interactions
  • Human Papillomavirus
  • Human Papillomavirus Vaccine, Bivalent
  • Human Papillomavirus Vaccine, Quadrivalent
  • Hypersensitivity
  • Hyposensitivity
  • Immune Evasion
  • Immune Globulin
  • Immune System
  • Immunity
  • Immunization
  • Immunosupression
  • Inactivated Influenza Vaccine, Quadrivalent
  • Inactivated Influenza Vaccine, Trivalent
  • Inactivated Poliovirus Vaccine
  • Inactivated Vaccine
  • Incubation Period
  • Infant Immunity
  • Infection
  • Infectious Agents
  • Inflammation
  • Inflammatory Bowel Disease (IBD)
  • Influenza
  • Innate Immunity
  • Investigational Vaccine
  • Japanese Encephalitis
  • Jaundice
  • Listeriosis
  • Live Oral Typhoid Vaccine
  • Live Vaccine
  • Live, Attenuated Influenza Vaccine (Nasal Spray)
  • Live, Attenuated Influenza Vaccine (Quadrivalent)
  • Lymphocytes
  • Malaria
  • Malaria Vaccines
  • Measles, Mumps & Rubella Vaccine
  • Measles, Mumps, Rubella & Varicella Vaccine
  • Measles-rubella Vaccine
  • Meningococcal Conjugate Vaccine (Quadravalent)
  • Meningococcal Conjugate Vaccine, Quadrivalent
  • Meningococcal Conjugate Vaccine, Quadrivalent
  • Meningococcal Polysaccharide Vaccine (Quadravalent)
  • Meningoencephalitis
  • Microbes
  • Mucosal Membranes
  • Multiple Sclerosis
  • Neuropathy
  • Otitis Media
  • Parasitology
  • Passive Immunity
  • Pathogenesis
  • Pathogens
  • Pertussis
  • Placebo
  • Pneumococcal Conjugate Vaccine (13-valent)
  • Pneumococcal Polysaccharide Vaccine (23-valent)
  • Poliomyelitis
  • Polysaccharide Vaccines
  • Potency
  • Prevalence
  • Public Health
  • Quadrivalent HPV Vaccine
  • Recombinant
  • Recombinant Influenza Vaccine, Trivalent
  • Recombinant Zoster Vaccine
  • Respiratory Diseases
  • Rotavirus
  • Rotavirus Vaccine, Monovalent
  • Rotavirus Vaccine, Pentavalent
  • Rubella
  • Seizure
  • Serogroup B Meningococcal Vaccine
  • Serogroup B Meningococcal Vaccine
  • Serogroup B Meningococcal Vaccine
  • Severe Combined Immune Deficiency (SCID)
  • Shingles
  • Side Effect
  • Smallpox
  • Sudden Infant Death Syndrome (SIDS)
  • Tetanus
  • Toll-like Receptors
  • Tuberculosis
  • Typhoid Fever
  • Vaccination
  • Vaccination Campaigns
  • Vaccine Adverse Event Reporting System (VAERS)
  • Vaccine Business And Development
  • Vaccine Clinical Development Programmes
  • Vaccine Effectiveness
  • Vaccine R&D Projects
  • Vaccine Safety Datalink Project (VSD)
  • Vaccines - Administration And Dosage
  • Vaccines - Production And Control
  • Vaccines - Quality Testing
  • Vaccines - Research And Development Strategies
  • Vaccines - Standards
  • Vaccines Adjuvant
  • Vaccines And Related Substances
  • Vaccines Control
  • Vaccines Market
  • Vaccines Supply
  • Vaccinia
  • Varicella
  • Varicella Vaccine
  • Varicella Zoster Virus
  • Veterinary Science
  • Virion Assembly
  • Virology
  • Virulence
  • Virus
  • Waning Immunity
  • Whooping Cough
  • Yellow Fever
  • Zoster Vaccine Live